Minghua Yu

1.0k total citations
47 papers, 811 citations indexed

About

Minghua Yu is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, Minghua Yu has authored 47 papers receiving a total of 811 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Cancer Research and 9 papers in Hematology. Recurrent topics in Minghua Yu's work include Acute Myeloid Leukemia Research (8 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Hematological disorders and diagnostics (5 papers). Minghua Yu is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Hematological disorders and diagnostics (5 papers). Minghua Yu collaborates with scholars based in China, United States and South Korea. Minghua Yu's co-authors include Peilin Cui, Ruijuan Xiu, Jianqun Han, Min Dai, Hongwei Li, Zhao-Xu Yang, Xianzhi Guo, Zhenya Zhang, Peng Zhang and Lili Gao and has published in prestigious journals such as Nature Communications, Biomaterials and Scientific Reports.

In The Last Decade

Minghua Yu

46 papers receiving 799 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minghua Yu China 18 353 218 137 109 85 47 811
Michael F. Coleman United States 15 257 0.7× 165 0.8× 67 0.5× 126 1.2× 82 1.0× 46 627
Zhiqin Li China 14 265 0.8× 98 0.4× 154 1.1× 117 1.1× 113 1.3× 42 716
Karolina Jabłońska Poland 18 290 0.8× 138 0.6× 124 0.9× 265 2.4× 84 1.0× 50 890
Toni Segovia‐Silvestre Denmark 14 335 0.9× 82 0.4× 65 0.5× 141 1.3× 66 0.8× 20 759
Zhen Xiang China 15 467 1.3× 299 1.4× 70 0.5× 266 2.4× 67 0.8× 28 1.1k
Chisaka Kuehnemann United States 9 689 2.0× 177 0.8× 59 0.4× 79 0.7× 132 1.6× 10 1.5k
Liankun Gu China 21 736 2.1× 315 1.4× 39 0.3× 135 1.2× 42 0.5× 53 1.1k
Domhnall McHugh United Kingdom 7 486 1.4× 99 0.5× 42 0.3× 54 0.5× 89 1.0× 7 1.1k
Jessica L. Bowser United States 14 286 0.8× 152 0.7× 28 0.2× 152 1.4× 56 0.7× 25 700
Rekha Kar United States 15 792 2.2× 115 0.5× 36 0.3× 139 1.3× 135 1.6× 23 1.1k

Countries citing papers authored by Minghua Yu

Since Specialization
Citations

This map shows the geographic impact of Minghua Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minghua Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minghua Yu more than expected).

Fields of papers citing papers by Minghua Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minghua Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minghua Yu. The network helps show where Minghua Yu may publish in the future.

Co-authorship network of co-authors of Minghua Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Minghua Yu. A scholar is included among the top collaborators of Minghua Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minghua Yu. Minghua Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hu, Lina, et al.. (2025). MUC3A promotes the progression of cholangiocarcinoma through the MAPK/ERK pathway. Discover Oncology. 16(1). 493–493. 1 indexed citations
3.
Su, Wei, et al.. (2024). MDH2 regulates the sensitivity of clear cell renal cell carcinoma to ferroptosis through its interaction with FSP1. Cell Death Discovery. 10(1). 363–363. 9 indexed citations
4.
Wang, Yang, et al.. (2023). Preparation and study of modified phytic acid/epoxy resin anti-corrosion coating. Colloid & Polymer Science. 302(1). 117–127. 2 indexed citations
5.
Wang, Jingyan, Xiaoyan Ding, Yawen Xu, et al.. (2023). Clinical study of lenvatinib in the treatment of hepatitis virus-related hepatocellular carcinoma and antiviral therapy. Frontiers in Pharmacology. 13. 1032881–1032881. 4 indexed citations
6.
Shi, Tingting, Huifeng Fan, Minghua Yu, et al.. (2023). Impact of extracorporeal membrane oxygenation in immunocompetent children with severe adenovirus pneumonia. BMC Pulmonary Medicine. 23(1). 41–41. 5 indexed citations
7.
Liang, Yongjun, et al.. (2022). Alteration of Ileal lncRNAs After Duodenal–Jejunal Bypass Is Associated With Regulation of Lipid and Amino Acid Metabolism. Frontiers in Physiology. 13. 836918–836918. 1 indexed citations
8.
Yang, Yunkai, Xiaohan Guo, Bo Hu, et al.. (2020). Generated SecPen_NY-ESO-1_ubiquitin-pulsed dendritic cell cancer vaccine elicits stronger and specific T cell immune responses. Acta Pharmaceutica Sinica B. 11(2). 476–487. 15 indexed citations
9.
Zhang, Gensheng, Qin Wang, Wenwen Wang, et al.. (2018). Tempol Protects Against Acute Renal Injury by Regulating PI3K/Akt/mTOR and GSK3β Signaling Cascades and Afferent Arteriolar Activity. Kidney & Blood Pressure Research. 43(3). 904–913. 27 indexed citations
10.
Gao, Lili, Xiaoping Yang, Hao Zhang, et al.. (2018). Inhibition of miR-10a-5p suppresses cholangiocarcinoma cell growth through downregulation of Akt pathway. OncoTargets and Therapy. Volume 11. 6981–6994. 20 indexed citations
11.
Guo, Xianzhi, Xiaolei Ye, Weizhong Xiao, et al.. (2015). Downregulation of VMP1 confers aggressive properties to colorectal cancer. Oncology Reports. 34(5). 2557–2566. 21 indexed citations
12.
Ko, Frankie Chi Fat, Lo‐Kong Chan, Karen Man‐Fong Sze, et al.. (2013). PKA-induced dimerization of the RhoGAP DLC1 promotes its inhibition of tumorigenesis and metastasis. Nature Communications. 4(1). 1618–1618. 29 indexed citations
13.
Ke, Qing, et al.. (2012). Identification of the PAG1 Gene as a Novel Target of Inherent Radioresistance in Human Laryngeal Carcinoma Cells. Cancer Biotherapy and Radiopharmaceuticals. 27(10). 678–684. 10 indexed citations
14.
Min, Xinwen, et al.. (2012). PI3K-like kinases restrain Pim gene expression in endothelial cells. Journal of Huazhong University of Science and Technology [Medical Sciences]. 32(1). 17–23. 3 indexed citations
15.
16.
Li, Lin, et al.. (2009). [Study on karyotypic abnormalities and its prognostic significance in Chinese patients with primary myelodysplastic syndromes].. PubMed. 30(4). 217–22. 4 indexed citations
17.
Li, Lin, et al.. (2009). Unique cytogenetic features of primary myelodysplastic syndromes in Chinese patients. Leukemia Research. 33(9). 1194–1198. 21 indexed citations
18.
Yu, Minghua, Jianqun Han, Peilin Cui, et al.. (2008). Cisplatin up‐regulates ICAM‐1 expression in endothelial cell via a NF‐κB dependent pathway. Cancer Science. 99(2). 391–397. 42 indexed citations
19.
Cui, Peilin, Minghua Yu, Ming Dai, et al.. (2007). Intracellular signaling pathways involved in cell growth inhibition of human umbilical vein endothelial cells by melatonin. Journal of Pineal Research. 44(1). 107–114. 67 indexed citations
20.
Dai, Min, Peilin Cui, Minghua Yu, et al.. (2007). Melatonin modulates the expression of VEGF and HIF‐1α induced by CoCl2 in cultured cancer cells. Journal of Pineal Research. 44(2). 121–126. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael F. Coleman Breakdown of academic impact, for papers by Zhiqin Li Breakdown of academic impact, for papers by Karolina Jabłońska Breakdown of academic impact, for papers by Toni Segovia‐Silvestre Breakdown of academic impact, for papers by Zhen Xiang Breakdown of academic impact, for papers by Chisaka Kuehnemann Breakdown of academic impact, for papers by Liankun Gu Breakdown of academic impact, for papers by Domhnall McHugh Breakdown of academic impact, for papers by Jessica L. Bowser Breakdown of academic impact, for papers by Rekha Kar
Rankless by CCL
2026